These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 18991890)
1. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption. Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890 [TBL] [Abstract][Full Text] [Related]
2. Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats. Ting CH; Chi CW; Li CP; Chen CY Nutrition; 2015 Jan; 31(1):230-5. PubMed ID: 25466669 [TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system. Kruk-Slomka M; Michalak A; Biala G Behav Brain Res; 2015 May; 284():24-36. PubMed ID: 25660201 [TBL] [Abstract][Full Text] [Related]
4. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950 [TBL] [Abstract][Full Text] [Related]
5. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents. Bi GH; Galaj E; He Y; Xi ZX Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752 [TBL] [Abstract][Full Text] [Related]
6. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats. Delis F; Polissidis A; Poulia N; Justinova Z; Nomikos GG; Goldberg SR; Antoniou K Int J Neuropsychopharmacol; 2017 Mar; 20(3):269-278. PubMed ID: 27994006 [TBL] [Abstract][Full Text] [Related]
9. Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus. Zheng L; Wu X; Dong X; Ding X; Song C Alcohol Clin Exp Res; 2015 Oct; 39(10):1908-16. PubMed ID: 26343919 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490 [TBL] [Abstract][Full Text] [Related]
11. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Klegeris A; Bissonnette CJ; McGeer PL Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain. Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273 [TBL] [Abstract][Full Text] [Related]
13. Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands. Kruk-Slomka M; Boguszewska-Czubara A; Slomka T; Budzynska B; Biala G Neural Plast; 2016; 2016():9815092. PubMed ID: 26839719 [TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide. Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201 [TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour. Grey J; Terry P; Higgs S Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336 [TBL] [Abstract][Full Text] [Related]
16. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387. McLaughlin PJ; Qian L; Wood JT; Wisniecki A; Winston KM; Swezey LA; Ishiwari K; Betz AJ; Pandarinathan L; Xu W; Makriyannis A; Salamone JD Pharmacol Biochem Behav; 2006 Mar; 83(3):396-402. PubMed ID: 16616951 [TBL] [Abstract][Full Text] [Related]
18. Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats. Werner NA; Koch JE Brain Res; 2003 Mar; 967(1-2):290-2. PubMed ID: 12650991 [TBL] [Abstract][Full Text] [Related]
19. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Onaivi ES Neuropsychobiology; 2006; 54(4):231-46. PubMed ID: 17356307 [TBL] [Abstract][Full Text] [Related]
20. Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Onaivi ES; Ishiguro H; Gong JP; Patel S; Meozzi PA; Myers L; Perchuk A; Mora Z; Tagliaferro PA; Gardner E; Brusco A; Akinshola BE; Liu QR; Chirwa SS; Hope B; Lujilde J; Inada T; Iwasaki S; Macharia D; Teasenfitz L; Arinami T; Uhl GR Ann N Y Acad Sci; 2008 Oct; 1139():434-49. PubMed ID: 18991891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]